In the written statement made by WHO, it was shared that Tocilizumab, which has been given intravenously to severe Kovid-19 patients, has significantly reduced the risk of death. In this context, it was noted that Kovid-19 treatment with Tocilizumab is the 7th treatment method that passed the prequalification of WHO.
PRICE OF A SINGLE DOSE 500-600 DOLLARS
It has been reported that for now, the drug will only be recommended for severe and critical patients and will be administered in clinical settings with standard Kovid-19 treatment equipment, under the supervision of healthcare professionals.
It was stated that a single dose of Tocilizumab is 500-600 dollars, but if more than one manufacturer enters the global market, its price may decrease.
IT HAS BEEN TRIED FOR A TIME
Tocilizumab, which is used in the treatment of rheumatoid arthritis in around 120 countries around the world, has been tested on severe patients for the treatment of Kovid-19 in some countries for a while.
The World Health Organization last recommended the use of rheumatoid arthritis drugs Baricitinib and Interleukin-6 in the treatment of Kovid-19 on January 14. (AA)